Welcome to LookChem.com Sign In|Join Free
  • or
4-[4-methoxy-3-nitrophenyl]-4-oxobutanoic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

26976-83-0

Post Buying Request

26976-83-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

26976-83-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 26976-83-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,6,9,7 and 6 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 26976-83:
(7*2)+(6*6)+(5*9)+(4*7)+(3*6)+(2*8)+(1*3)=160
160 % 10 = 0
So 26976-83-0 is a valid CAS Registry Number.

26976-83-0Relevant academic research and scientific papers

3(2H)-furanones promising candidates for synthesis of new fluorescent organic probes

Soliman, Mohamed H. A.,Hussein, Belal H. M.,Abdel-Moati, Nahla,El-Tamany, El-Sayed H. M.

, p. 567 - 575 (2019/05/21)

Several novel 3-arylidene-5-(4-memoxy-3-nitrophenyl)-2(3H)-furanones (2a-d) have been successfully prepared and used as precursors for building up of other new heterocyclic architectures such as pyrrolones (4a-c), (5) and unsaturated aroyl-hydrazides (7a-d). These aroyl-hydrazides have been subsequently converted into pyridazinone derivatives (8a-d) by refluxing in HCl/AcOH mixture. Eventually, benzoylation of the hydrazides (7a-c) with benzoyl chloride affords the corresponding N-benzoyl-3(2H)-pyridazinones (9a-c). The structures of all synthesized compounds have been established using elemental analysis and spectral methods. The photophysical (fluorescence and electronic absorption spectra) properties of newly synthesized compounds have also been investigated.

4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity

-

, (2008/06/13)

4-phenyl-4-oxo-butanoic acid derivatives for use in the treatment of the human or animal body by therepy; particularly as kynurenine-3-hydroxylase inhibitors, in the prevention and/or treatment of a neurodegenerative disease wherein the inhibition of such an enyzme is needed. The present invention further comprises a selected class of the above mentioned 4-phenyl-4-oxo-butanoic acid derivatives, their pharmaceutically acceptable salts, a process for their preparation and pharmaceutical compositions containing them.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 26976-83-0